Aim: To investigate the anti-inflammatory mechanism of the polysaccharides of Ginkgo biloba leaves (PGBL) by inhibiting leucocyte adhesion. Methods: The rough PGBL were isolated and purified. The anti-inflammatory effects of purified PGBL (p-PGBL) were assayed by ear edema induced by xylol and the acute peritonitis model in mice. The effect of p-PGBL on inhibiting the interaction between Pselectin and its ligands was investigated by flow cytometry and flow chamber. Results: p-PGBL could effectively inhibit the acute inflammation in mice and interfere with the adhesion of HL-60 cells, a human leukaemia cell line, or neutrophils to P-selectin in static conditions, as well as the adhesion of neutrophils to Chinese hamster ovary cells expressing human P-selectin and human umbilical vein endothelial cells in flow conditions in a dose-dependant manner. Conclusions: p-PGBL can inhibit the inflammatory process through interfering with the interaction between P-selectin and its ligands.
Introduction
Inflammation is a self-protective process under physiological conditions, but an extreme inflammatory reaction can result in the immune damage of organisms and cause pathological situations. A hallmark of inflammation is the adhesion of leucocytes to vascular endothelial cells (VEC) [1] . The binding of adhesion molecules expressed on leucocytes and VEC to their ligands is the critical molecular mechanism for this reaction [2, 3] . Selectin is one of the cell adhesion molecule families that mediate the adhesion of leucocytes to VEC, leucocytes to leucocytes, and leucocytes to platelets during inflammation. There are 3 kinds of selectins: P-, L-, and E-selectin, which function in different phases of cell adhesion [3] . P-selectin, a transmembrane glycoprotein expressed on the surface of activated platelets and VEC, acts as a receptor to mediate the initial adhesion of leucocytes [4] . In vivo, P-selectin antibodies can block leucocyte rolling and adhesion in venules and accumulating in tissues, and P-selectin-deficient mice exhibit severely diminished leucocyte rolling and delayed recruitment of leucocytes in various inflammatory tissues. As a result, the antagonists that block or interfere with the role of P-selectin may affect the inflammatory process [5] [6] [7] . In the past decade, several P-selectin antagonists have been developed, including mAb, sLe x , sLe a , heparin, as well as its mimetics. Although these antagonists have been shown to be effective in inhibiting P-selectin-mediated leucocyte adhesion and inflammation, they also exhibit various drawbacks, such as narrow cross-reactivity, weak affinity, and a short circulating half-life [8, 9] . Currently, much work has been focused on finding better inhibitors to prevent abnormal leucocyte emigration [10, 11] . Polysaccharides of Ginkgo biloba leaves (PGBL) are active components with multiple pharmacological functions, such as oxyradical and hydroxy radical clearance effects, anti-aging properties, antitumor activities, and immunomodulatory effects [12] [13] [14] . Rough PGBL have been reported to have anti-inflammatory effects, yet the mechanism remains unclear [15] . In this paper, we investigated the role and mechanism of purified PGBL (p-PGBL) on anti-inflammation and found that p-PGBL can inhibit P-selectin-mediated leucocyte adhesion and inflammation.
Materials and methods
Animals and cells BALB/c mice (5-6 weeks old) were purchased from the Experimental Research Center of Medical Animals in Changchun (China). Chinese hamster ovary (CHO) cells and HL-60 cells, a human leukaemia cell line, were bought from the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Shanghai, China). The CHO cells were cultured in Iscove's Modified Dulbecco's Medium (IMDM) and the HL-60 cells were cultured in RPMI-1640 medium at 37 °C in the presence of 5% CO 2 , and they were all supplemented with 10% inactivated fetal calf serum (FCS). Human neutrophils were isolated according to the Ficoll density gradient centrifugation method and maintained in RPMI-1640 medium without FCS. Human umbilical vein endothelial cells (HUVEC) were isolated by collagenase treatment as described previously [16, 17] . HUVEC were passaged by mild trypsinization (0.25% trypsin/0.02 EDTA) and cultured to confluence in 1% gelatin-coated 35 mm culture dishes. Before use in the adhesion assays, HUVEC were stimulated with 1 U/mL human thrombin for 10 min to obtain maximal levels of P-selectin expression [18] . Proteins and antibodies Recombinant human P-selectin/ Fc chimera protein (P-Fc) and blocking mAb to P-selectin (9E1) were obtained from R&D Systems (Minneapolis, Minnesota, USA). A non-blocking mAb to P-selectin (AC1. 2) was purchased from BD PharMingen (Franklin Lakes, New Jersey, USA). Goat antihuman fluorescein-isothiocyanate (FITC)-labeled immunoglobulin G (IgG) and goat antimouse IgG were purchased from Jackson Immuno-Research Laboratories (West Grove, Pennsylvania, USA). Collagenase and human thrombin were purchased from Sigma-Aldrich (St Louis, Missouri, USA).
Other reagents Sephadex G-75 was obtained from Pharmacia (North Peapack, New Jersey, USA). Thioglycollate broth was obtained from Sigma-Aldrich (USA). All other chemicals were of analytical grade.
Isolation and purification of PGBL Ginkgo biloba leaves were collected from Dandong, Liaoning Province. The PGBL were extracted from fresh Ginkgo biloba leaves according to routine methods [19] . To achieve p-PGBL, the PGBL were frozen and thawed repeatedly, ultrafiltrated by 30 000 ultrafiltration membranes, and freeze-dried. The powder was fractionalized by gel chromatography on a Sephadex G-75 column (4 cm×80 cm) and collected by an automatic fraction collector (BS-100A,Shanghai Huxi Analysis Instrument Factory Co. LTD, Shanghai, China). Then the fraction with the highest peak on the distribution curve was dialyzed, concentrated, and freeze-dried to obtain p-PGBL. p-PGBL purity was measured by gel chromatography on a Sephadex G-75 column (1.5 cm×95 cm) and HPLC, respectively. All gel chromatography was monitored with the phenol-sulfuric acid method. The molecular weight of p-PGBL was calculated according to the calibration curve obtained by using various standard dextrans. Nucleotides and proteins in p-PGBL were inspected by a UV spectrum assay. Optical rotation was measured with a WZZ-T 1 polarimeter (Shanghai Physical Optics Instrument, Shanghai, China). The polysaccharide component was determined by gas chromatography (GC) [20] .
Preparation of CHO cells expressing human P-selectin
Full-length human P-selectin cDNA, subcloned in a pcDNA 3.1 (-) vector, was a kind gift from Dr Spertini O (Centre Hospitalier Universitaire Vaudois, Lausanne Switzerland). The cDNA was 2500 base pairs in length, and were inserted in pcDNA3.1 (-) plasmids at the EcoRV and NotI cloning sites. Then th e plasmids were tr ansfected by an electroporation apparatus (160 V; Gene Pulser X cellTM, BIO-RAD, Hercules, California, USA) into CHO cells, which do not express P-selectin. The transfected CHO cells were selected with G418, and the monoclones of the cells that steadily expressed human P-selectin were selected for the cell adhesion experiment under flow conditions [21] . Ear edema in mice induced by xylene The mice (18~22 g) were randomly divided into 5 individual groups with 8 (sex ratio 1:1) in each group. Each group of mice was intraperitoneally injected with 12.5, 25, and 50 mg/kg p-PGBL or 2 mg/kg dexamethasone (negative control) or 2 mg/kg sterile saline (positive control), respectively, and the injection interval was 12 h. Thirty minutes after the third injection, a topical edema was induced in each mouse by applying 0.05 mL xylene to both sides of the right ear of each mouse. The mice were killed by luxation method 0.5 h after inflammation was developed, and an 8 mm diameter round slice was cut from the same sites of both ears by using a perforator. The slices were then weighed. The edema level was assessed in terms of the increase in the weight of the right ear piece over that of the left ear. The mean of the difference between the right and left ears was determined for each group. The inhibition percentages were calculated by comparison with the positive control group that only received the xylene application but none of the treatments [15, 22] .
Thioglycollate-induced peritoneal inflammation
In each experimental test, the male mice were randomly separated into 6 individual groups and intraperitoneally injected with 2 mL of 3% thioglycollate broth or sterile pyrogen-free saline. Five minutes later, the mice were intravenously injected with 0.2 mL of either sterile pyrogen-free saline or different concentration of p-PGBL. The mice were killed after 3 h, and their peritoneal cavities were lavaged with 2 mL phosphatebuffered saline (PBS) [18] . One part of the total peritoneal cells was double-blindly counted with a hemocytometer, while the other part of the cells was fixed and stained with WrightGiemsa. Neutrophils were counted under a microscope (15-20 counts/slide for a total of 800 cells) and neutrophils/mL were calculated.
Flow cytometric assays For the cell surface P-selectin binding assay, P-Fc (0.3 µg) was pre-incubated with PBS supplemented with 1 mmol CaCl 2 and 1 mmol MgCl 2 , mAb 9E1, or different concentration of p-PGBL at 37 °C for 30 min. Then 100 µL HL-60 cells or human neutrophils (5×10 9 /L) were added and the mixture was incubated at 4 °C for 30 min. After incubation, the cells were washed once, resuspended in 100 µL RPMI-1640 medium containing FITC-labeled goat antihuman IgG (2 mg/L), and incubated at 4 °C for another 30 min. The cells were then washed twice, and 10 000 cells were counted for flow cytometric analysis with a FACScan (Becton Dickinson, Franklin Lakes, New Jersey, USA) [18] . Flow chamber assays CHO cells, CHO cells expressing human P-selectin (CHO-P), and HUVEC (4×10 8 /L) were seeded in 35 mm culture dishes, respectively, to allow cell monolayers to form. Then mAb 9E1 and different concentration of p-PGBL were added, separately. After the cells were incubated in a CO 2 incubator for 30 min, the dishes were assembled in a parallel-plate flow chamber (GlycoTech, Rochville, MD, USA) and mounted on the objective table of an inverted microscope (Olympus Optical, Tokyo, Japan). After washing the flow chamber with Dulbecco's PBS containing 0.1% bovine serum albumin for 2 min, 2×10 9 /L human neutrophils were perfused through the chamber at a appropriate flow rate to obtain wall shear stress of 0.12 Pa at 22 °C by using a syringe pump (Cole-Parmer Instrument Company, Vernon Hills, Illinois, USA), thereby mimicking the fluid mechanical environment of the microcirculation and postcapillary venules. After the appearance of the neutrophils, the field was randomly selected and recorded via the camera (Panasonic, Yokohama, Japan) connected to the inverted microscope. The video was later transferred to a computer. Each sample had 3 dishes, and each dish was measured for 3 min. The mean value was calculated from 3 trials. The number of neutrophils attached to CHO cells, CHO-P cells, and HUVEC per unit time and area was manually determined by reviewing the videos. The relative adhesion rate of the different concentration of p-PGBL was calculated [18, 23] . Statistical analysis Data were expressed as the mean±SEM. The statistical significance of differences between means was determined by ANOVA. If the means were shown to be significantly different, multiple comparisons by pairs were performed with the Tukey test. Probability values of P< 0.05 or P<0.01 were selected to be statistically significant.
Results

PGBL extraction and purification
Water-soluble brown-white powder was isolated from Ginkgo biloba leaves and the yield rate was 8.6%. The white powder (p-PGBL) was obtained by deproteinization, ultrafiltration and gel chromatography on a Sephadex G-75 column and freezedried. The purity of p-PGBL was confirmed by gel chromatogram on a Sephadex G-75 column and HPLC, and showed that the symmetrical peak that appeared at 16.54 min was consistent with the PGBL peak that had the highest polysaccharide content (Figure 1 ). An absorption spectrum at 260-280 nm was not detected by the UV spectrum assay, indicating that neither nucleotides nor proteins were presented in p-PGBL. According to the standard curve, the relative molecular weight of p-PGBL was ~10 kDa, and the purity was 98.8%. Optical rotation was (a) 20 n =+43. Analyzed by GC, the monosaccharide composition was Gal, Man, Glu, Ara, Rha and galacturonic, and the molar ratio was 6:2.4:1.7:4.6:6.8:1. 
p-PGBL inhibits acute inflammation in mice
To investigate the anti-inflammatory effect of p-PGBL, the acute inflammation model of ear edema in mice induced by xylene was first used in our experiment. As shown in Figure 2A , the ear edema in mice could be inhibited by p-PGBL at concentrations of 12.5, 25, and 50 mg/kg. Compared with the positive control mice (the sterile saline-injected mice), the inhibition rates of p-PGBL were 36.8%, 56.09%, and 64.27%, respectively. The inhibition effect of the p-PGBL was dose dependent. Then we further investigated the anti-inflammatory effect of p-PGBL by using the well-established acute peritonitis model in mice. The results showed that the thioglycollate injection greatly increased the neutrophils in the peritoneal cavity. Compared with the positive control mice (the thioglycollate-injected mice), 5 and 25 mg/kg p-PGBL could inhibit thioglycollate-induced neutrophil transmigration with an inhibition rate of 46.43% and 78.11%, respectively, and 50 mg/kg p-PGBL could entirely block thioglycollate-induced neutrophil transmigration ( Figure 2B ). The data suggest that p-PGBL has obvious inhibitory effects on acute inflammation, and p-PGBL can alleviate acute inflammation through inhibiting neutrophil transmigration in a dose-dependent manner.
p-PGBL inhibits P-selectin binding to leucocytes in static conditions
In acute inflammation, leucocyte transmigration is a multistep process, and P-selectin plays a critical role in the initial leucocyte rolling and adhesion to endothelial cells. Many studies have shown that the binding of P-selectin to its ligands could be inhibited by several natural carbohydrates [8, 24, 25] . To assess whether the effects of p-PGBL on leucocyte transmigration in acute inflammation are due to the inhibition of the interaction of P-selectin with its ligands, we performed adhesion assays using HL-60 cells, which are human leukemic cells expressing P-selectin ligand, and human neutrophils by flow cytometry. As shown in Figure 3A and 3B, P-selectin bound to HL-60 or neutrophils steadily, and human P-selectin blocking mAb (9E1) could entirely block the binding. At the concentrations of 0.1 g/L and 0.5 g/L, p-PGBL exhibited a strong inhibitory effect on P-selectin binding. The results confirmed the involvement of P-selectin in acute inflammation and indicated that p-PGBL could inhibit P-selectin binding to its ligands.
p-PGBL inhibits neutrophil adhesion to CHO-P To further investigate the molecular mechanisms of the anti-inflammatory activity of p-PGBL, CHO-P cells steadily expressing human P-selectin ( Figure 4A ) and CHO-P monolayers cultured in a 35 mm plate ( Figure 4B ) were prepared to mimic the activated VEC. Then the inhibitory effect of p-PGBL was examined under a condition that was close to the physiological blood flow rate (0.12 Pa). As illustrated in Figure 4C , p-PGBL exhibited a strong inhibitory effect on neutrophils rolling and adhesion to CHO-P cells at the concentrations of 0.1 g/L and 0.5 g/L. Compared with the positive control, the inhibitory rates of p-PGBL at the concentrations of 0.1 g/L and 0.5 g/L were 71.38% and 87.61%, respectively. These findings indicate that under a physiological blood flow rate, p-PGBL can inhibit P-selectin-mediated leucocyte adhesion in a dose-dependent manner.
p-PGBL inhibits neutrophil adhesion to HUVEC VEC, when stimulated or activated, can express P-selectin to mediate leucocyte adhesion [2, 26] . To investigate the anti- inflammatory effect of p-PGBL under physiological conditions, we further examined the interaction of neutrophils and HUVEC. As illustrated in Figure 5 , the treatment of HUVEC monolayers ( Figure 5A ) with human thrombin (1 U/mL) dramatically increased the number of neutrophil rolling and adhesion to HUVEC, and blocking mAb to Pselectin (9E1) partly inhibited neutrophil rolling and adhesion; p-PGBL, at the concentrations of 0.1 g/L and 0.5 g/L, dramatically inhibited the rolling and adhesion. These results showed that the inhibition of p-PGBL in neutrophil adhesion to HUVEC is mainly P-selectin mediated.
Discussion
Plant polysaccharides are natural, non-toxic substances with multiple biological activities. Many plant polysaccharides, such as Radix astragali, Lentinus edodes, and Agaricus blazei Muri, have been shown to possess anti-acute inflammatory effects [27] [28] [29] . Song et al found that rough PGBL exhibit evident anti-inflammatory activity due to the inhibition of ear swelling and the capillary permeability in mice, but the mechanism has not been clearly understood as yet [15] . In the present study, the rough PGBL was further purified by gel chromatography, and the purified fraction was found to have a uniform molecular weight (Figure 1 ). The anti-inflammatory effect of p-PGBL was detected by examining the ear edema in mice and peritoneal transmigration of neutrophils in the mouse acute inflammatory model. We found that p-PGBL could significantly decrease ear edema in mice and peritoneal deposition of neutrophils in a dose-dependent manner (Figure 2A, 2B) . Compared with the findings of Song et al, our p-PGBL could preserve better antiinflammatory activity even at a lower concentration due to the inhibition of ear edema and the blockage of neutrophil transmigration.
It has been widely reported that P-selectin plays a critical role in initial leucocyte rolling and adhesion to endothelial cells on the inflammatory sites by interacting with its major ligand PSGL-1 [30, 31] . Any antagonist that can block the interaction of P-selectin and its ligands is likely to be effective in inhibiting the inflammatory process [32, 33] . Here, we showed that p-PGBL can effectively block the interaction between Pselectin and HL-60 cells or neutrophils ( Figure 3A, 3B) , implying that the inhibitory effect of p-PGBL in anti-inflammation is mainly due to the interference of P-selectin binding to its ligands. This observation was further confirmed with CHO-P and HUVEC cells by the flow chamber assay conducted under physiological conditions (Figures 4,5) .
Leukocyte recruitment during acute and chronic inflammatory responses is a multistep process regulated by a variety of adhesion molecules and inflammatory factors [34] . In in vitro experiments, we found that P-selectin blocking mAb (9E1) almost totally blocked the adhesion of neutrophils to CHO-P, but only partly blocked the adhesion of neutrophils to HUVEC (Figures 4C,5B) , implying that other adhesion molecules on HUVEC also functioned in the rolling process. Our results also showed that p-PGBL could more effectively block the adhesion of neutrophils to HUVEC than P-selectin blocking mAb, suggesting that, besides P-selectin, p-PGBL also interfered with the interactions of other adhesion molecules or inflammatory factors in this process. These results were also confirmed by the ear edema in mice and acute peritonitis experiments in vivo (Figure 2A,2B) . We also found that at a concentration of 0.01g/L, p-PGBL could effectively inhibit neutrophil adhesion to HUVEC in vitro ( Figure 5B ), but the inhibitory effects of p-PGBL on neutrophil transmigration in vivo was not obvious at the concentration of 0.5 mg/kg, approximating to 0.01g/L (1 mL blood/20 g weight mouse; Figure 2B ). These results indicated that a higher concentration of p-PGBL is required for inhibiting neutrophil transmigration and inflammation in vivo.
Inflammation can be divided into specific and nonspecific. At present, we still have not obtained better drugs to treat non-specific inflammation. Although some drugs, such as hormones, have been effective in treating non-specific inflammation diseases, they exhibited strong side-effects. As a natural, non-toxic substance, p-PGBL has demonstrated its effect in inhibiting neutrophil transmigration and inflammation in vivo. We believe that p-PGBL is a promising drug for the clinical application of non-specific inflammation diseases by offering higher efficiency and reducing side-effects. 
